BB BIOTECH
BB Biotech is an equity fund launched and managed by Bellevue Asset Management. It invests in the public equity markets across the globe. BB Biotech primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. It employs a fundamental analysis to create its portfolio. BB Biotech began operation on November 09, 1993. It has its headquarters in Schaffhausen in Switzerland.
BB BIOTECH
Industry:
Alternative Medicine Biotechnology Health Care Pharmaceutical Professional Services
Founded:
1993-11-09
Address:
Schaffhausen, Schaffhausen, Switzerland
Country:
Switzerland
Website Url:
http://www.bbbiotech.ch
Total Employee:
1+
Status:
Active
Contact:
+41526240845
Email Addresses:
[email protected]
Total Funding:
224.91 K USD
Technology used in webpage:
Apple Mobile Web Clips Icon WordPress Google Maps Content Delivery Network SSL By Default Global Site Tag HSTS Google Universal Analytics JsDelivr Google Analytics 4
Similar Organizations
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-11 | AveXis | AveXis acquired by BB Biotech | N/A |
Official Site Inspections
http://www.bbbiotech.ch Semrush global rank: 9.17 M Semrush visits lastest month: 432
- Host name: 67.188.148.5.ptr.at-nine.ch
- IP address: 5.148.188.67
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "BB Biotech"
BB Biotech AG Organizational Regulations (Final Draft) Website
In this function, the Company, with employees in its own offices in Schaffhausen, performs tasks of manage- ment, organization as well as financing for itself and for its Subsidiaries, with …See details»
BB Biotech AG
By using the website www.bbbiotech.com, you confirm that you have read, understood and accepted the general information provided by the BB Biotech AG as well as these legal …See details»
BB Biotech - Wikipedia
As a closed-end fund, with its principal activity of specialised investments in companies operating in the biotech sector, BB Biotech is the oldest established and largest entity of its kind. Primary focus lies on small-to-mid-cap biotech companies headquartered in Western Europe and especially the United States market. The biotechnology companies in which BB Biotech invests are active, for example, in the fields of See details»
BB Biotech - Annual Report 2024 - report.bbbiotech.ch
Dec 31, 2024 In BB Biotech's 2024 digital annual report, you will quickly find relevant information on the 2024 financial year, the top story about artificial intelligence in the biotech sector as well …See details»
BB Biotech - Annual Report 2020 - report.bbbiotech.ch
BB Biotech AG controls and is the ultimate parent company of its subsidiaries (Subsidiaries). Together they form the BB Biotech Group (Group). In this function, the Company performs …See details»
Key Information Document - fundslibrary.co.uk
How can I complain? Complaints can be filed through the company. BB Biotech AG Schwertstrasse 6 8200 Schaffhausen Switzerland [email protected] Other relevant …See details»
Unternehmensprofil - Geschäftsbericht 2023 - report.bbbiotech.ch
BB Biotech investiert in Gesellschaften des Wachstumsmarkt Biotechnologie und ist einer der weltweit grössten Anleger mit 30 Jahren Erfahrung in diesem Bereich. Die Aktie von BB …See details»
Company - About BB Biotech | BB Biotech AG
By using the website www.bbbiotech.com, you confirm that you have read, understood and accepted the general information provided by the BB Biotech AG as well as these legal …See details»
BB Biotech AG publishes its 2024 annual report
Feb 21, 2025 This marks a continuation of the dividend policy of the previous years. BB Biotech’s annual report 2024 is available under report.bbbiotech.ch/2024/en resp. …See details»
Company Profile - BB Biotech
Company Profile Excellence in Biotech Investments The access to fast growing biotechnology companies BB Biotech invests in companies in the fast growing market of biotechnology and is …See details»
BB Biotech – Wikipedia
BB Biotech beteiligt sich seit der Gründung in 1993 vorwiegend an klein- bis mittelkapitalisierten börsennotierten Unternehmen, [12] die neue Medikamente entwickeln und vermarkten, [13] …See details»
Put Warrants auf BB Biotech AG - BX Swiss
Established in 1884, BX Swiss is a Swiss regulated stock exchange under the supervision of FINMA.See details»
BB Biotech Aktie (BION) | Aktienkurs - wallstreetONLINE
2 days ago BION | BB Biotech Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der BB Biotech Aktie Analysiere mit wallstreetONLINESee details»
BB Biotech AG
Durch die Benutzung der Webseite www.bbiotech.com bestätigen Sie, die generellen wichtigen Hinweise der BB Biotech AG und die nachfolgenden Bestimmungen gelesen, verstanden und …See details»
BB Biotech AG veröffentlicht Geschäftsbericht 2024
Feb 21, 2025 Damit wird die bisherige Ausschüttungspolitik weitergeführt. Der vollständige Geschäftsbericht 2024 der BB Biotech AG ist auf report.bbbiotech.ch/2024/de resp. …See details»
tendendo - English translation – Linguee
Many translated example sentences containing "tendendo" – English-Italian dictionary and search engine for English translations.See details»
Company profile - Annual Report 2021
Company Profile Excellence in Biotech Investments The access to fast growing biotechnology companies BB Biotech invests in companies in the fast growing market of biotechnology and is …See details»
Corporate News - Investoren | BB Biotech AG
Diese Website benutzt Cookies, die für den technischen Betrieb der Website erforderlich sind und stets gesetzt werden. Andere Cookies, um Inhalte zu personalisieren und die Zugriffe auf …See details»
BB Biotech - Annual Report 2020
In BB Biotech's 2020 digital annual report, you will quickly find relevant information on the 2020 financial year, exciting stories such as about the mRNA technology, as well as trends for 2021. …See details»
Company profile - Annual Report 2020 - report.bbbiotech.ch
In BB Biotech's 2020 digital annual report, you will quickly find relevant information on the 2020 financial year, exciting stories such as about the mRNA technology, as well as trends for 2021. …See details»